Ofatumumab for Chronic Lymphocytic Leukemia User Reviews
Brand names: Kesimpta, Arzerra
Ofatumumab has no reviews submitted for this condition. Be the first to review this drug.
Learn more about Chronic Lymphocytic Leukemia
Care guides
Symptoms and treatments
More about ofatumumab
- Check interactions
- Compare alternatives
- Reviews (61)
- Side effects
- Dosage information
- During pregnancy
- Drug class: CD20 monoclonal antibodies
- Breastfeeding
- En español
